(19)
(11) EP 4 580 679 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23861512.4

(22) Date of filing: 30.08.2023
(51) International Patent Classification (IPC): 
A61K 45/06(2006.01)
A61K 31/27(2006.01)
A61P 29/00(2006.01)
C07D 405/04(2006.01)
A61K 31/135(2006.01)
A61P 25/00(2006.01)
C07D 235/30(2006.01)
C07D 471/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/27; A61K 45/06; A61P 25/00; A61P 29/00; A61K 31/167; A61K 31/472; A61K 31/4402; A61K 31/4439
 
C-Sets:
  1. A61K 31/27, A61K 2300/00;
  2. A61K 31/4439, A61K 2300/00;
  3. A61K 31/472, A61K 2300/00;
  4. A61K 31/4402, A61K 2300/00;
  5. A61K 31/167, A61K 2300/00;

(86) International application number:
PCT/US2023/073125
(87) International publication number:
WO 2024/050389 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 30.08.2022 US 202263402416 P

(71) Applicant: Biohaven Therapeutics Ltd.
Tortola VG1110 (VG)

(72) Inventor:
  • CORIC, Vladimir
    New Haven, Connecticut 06510 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS AND NMDA RECEPTOR ANTAGONISTS